Company Summary
Search
Home Page
 
*Acasti Pharma Inc. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
February 29DelistN
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
1/Feb/2002 27/Mar/2023 Canada Quebec  
Exchange Filing Office
Location
(not available)
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  *Research and Development in the Physical, Engineering and Life Sciences  News Release April 29, 2015-Acasti is an emerging biopharmaceutical company focused on the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment and prevention of certain cardiometabolic disorders, in particular abnormalities in blood lipids, also known as dyslipidemia. Because krill feeds on phytoplankton (diatoms and dinoflagellates), it is a major source of phospholipids and polyunsaturated fatty acids ("PUFAs"), mainly eicosapentaenoic acid ("EPA") and docosahexaenoic acid ("DHA"), which are two types of omega-3 fatty acids well known to be beneficial for human health. CaPre(R), currently Acasti's only prescription drug candidate, is a highly purified omega-3 phospholipid concentrate derived from krill oil and is being developed to help prevent and treat hypertriglyceridemia, which is a condition characterized by abnormally high levels of triglycerides in the bloodstream. 
Securities
SymbolSecurity NameMarketStatus
*ACST*Acasti Pharma Inc.TSX VentureDELIST
*ACST*Acasti Pharma Inc oldTSX VentureDELIST
*APO*Acasti Pharma Inc oldTSX VentureDELIST
*APO*Acasti Pharma Inc. OldTSX VentureDELIST
*APO.RT*Acasti Pharma Inc rt ex 14sept2011TSX VentureDELIST
Name HistoryFromTo
*Acasti Pharma Inc.1/Feb/200227/Mar/2023
Company Facts Reconciliation
SubjectDate Returned
Spring 2015 CFR Not Received
Associations
Auditing Firm:  *KPMG LLP
Sponsor:  *Versant Partners Inc.
Transfer Agent:  *Computershare Investor Services Inc.
Latest Information
TypeDateTitle
News Releases  4/Oct/2018  NEWS RELEASE - HALT[MARKET NEWS]
    NEWS RELEASE - IIROC TRADING RESUMPTION ACST[MARKET NEWS]
    NEWS RELEASE - IIROC TRADING HALT ACST[MARKET NEWS]
Bulletins  13/Mar/2023  Delist
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
(not available)

* Historical Data